CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech

By /

Motion to transfer U.S. litigation to Eastern District of Virginia granted at CureVac’s request and expected to significantly accelerate U.S. litigation timeline.

Scroll to Top